HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francisco Pozo-Rodríguez Selected Research

Adenosine Triphosphate (ATP)

10/2007Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francisco Pozo-Rodríguez Research Topics

Disease

4Neoplasms (Cancer)
01/2016 - 10/2007
2Lung Neoplasms (Lung Cancer)
01/2014 - 06/2004
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2014 - 11/2005
1Adenocarcinoma
01/2014
1Chromosomal Instability (Chromosome Stability)
01/2013
1Leukemia
01/2013
1Lymphoma (Lymphomas)
01/2013
1Inflammation (Inflammations)
10/2010
1Carcinoma (Carcinomatosis)
10/2007
1Neoplasm Metastasis (Metastasis)
11/2005

Drug/Important Bio-Agent (IBA)

2Benzene (Benzole)IBA
01/2016 - 01/2013
1Messenger RNA (mRNA)IBA
01/2014
1MicroRNAs (MicroRNA)IBA
01/2014
1Biomarkers (Surrogate Marker)IBA
01/2013
1InterleukinsIBA
10/2010
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2010
1Methacholine Chloride (Methacholine)FDA Link
10/2010
1InterferonsIBA
10/2010
1Proteins (Proteins, Gene)FDA Link
10/2007
1Glucose (Dextrose)FDA LinkGeneric
10/2007
1Adenosine Triphosphate (ATP)IBA
10/2007
1OligomycinsIBA
10/2007
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2005

Therapy/Procedure

2Thoracotomy
11/2005 - 06/2004
1Therapeutics
01/2014